Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Nucleic Acid 40μg
- 1.3.3 Nucleic Acid 30μg
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size & Forecast
- 1.5.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity (2021-2032)
- 1.5.3 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Zhejiang Wansheng Pharmaceutical
- 2.1.1 Zhejiang Wansheng Pharmaceutical Details
- 2.1.2 Zhejiang Wansheng Pharmaceutical Major Business
- 2.1.3 Zhejiang Wansheng Pharmaceutical BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Product and Services
- 2.1.4 Zhejiang Wansheng Pharmaceutical BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Zhejiang Wansheng Pharmaceutical Recent Developments/Updates
- 2.2 Shaanxi Medicine Holding Group Biological Products
- 2.2.1 Shaanxi Medicine Holding Group Biological Products Details
- 2.2.2 Shaanxi Medicine Holding Group Biological Products Major Business
- 2.2.3 Shaanxi Medicine Holding Group Biological Products BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Product and Services
- 2.2.4 Shaanxi Medicine Holding Group Biological Products BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Shaanxi Medicine Holding Group Biological Products Recent Developments/Updates
- 2.3 Jilin Yatai Biological Pharmaceutical
- 2.3.1 Jilin Yatai Biological Pharmaceutical Details
- 2.3.2 Jilin Yatai Biological Pharmaceutical Major Business
- 2.3.3 Jilin Yatai Biological Pharmaceutical BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Product and Services
- 2.3.4 Jilin Yatai Biological Pharmaceutical BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Jilin Yatai Biological Pharmaceutical Recent Developments/Updates
- 2.4 Chengdu Institute of Biological Products
- 2.4.1 Chengdu Institute of Biological Products Details
- 2.4.2 Chengdu Institute of Biological Products Major Business
- 2.4.3 Chengdu Institute of Biological Products BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Product and Services
- 2.4.4 Chengdu Institute of Biological Products BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Chengdu Institute of Biological Products Recent Developments/Updates
- 2.5 Hunan Jiuzhitang Siqi Biological
- 2.5.1 Hunan Jiuzhitang Siqi Biological Details
- 2.5.2 Hunan Jiuzhitang Siqi Biological Major Business
- 2.5.3 Hunan Jiuzhitang Siqi Biological BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Product and Services
- 2.5.4 Hunan Jiuzhitang Siqi Biological BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Hunan Jiuzhitang Siqi Biological Recent Developments/Updates
3 Competitive Environment: BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) by Manufacturer
- 3.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Revenue by Manufacturer (2021-2026)
- 3.3 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Manufacturer Market Share in 2025
- 3.4.3 Top 6 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Manufacturer Market Share in 2025
- 3.5 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market: Overall Company Footprint Analysis
- 3.5.1 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market: Region Footprint
- 3.5.2 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market: Company Product Type Footprint
- 3.5.3 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Region
- 4.1.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Region (2021-2032)
- 4.1.2 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Region (2021-2032)
- 4.1.3 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Average Price by Region (2021-2032)
- 4.2 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021-2032)
- 4.3 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021-2032)
- 4.4 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021-2032)
- 4.5 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021-2032)
- 4.6 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 5.2 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Type (2021-2032)
- 5.3 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 6.2 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Application (2021-2032)
- 6.3 Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Average Price by Application (2021-2032)
7 North America
- 7.1 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 7.2 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 7.3 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Country
- 7.3.1 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Country (2021-2032)
- 7.3.2 North America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 8.2 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 8.3 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Country
- 8.3.1 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Country (2021-2032)
- 8.3.2 Europe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Region
- 9.3.1 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 10.2 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 10.3 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Country
- 10.3.1 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Country (2021-2032)
- 10.3.2 South America BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Size by Country
- 11.3.1 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Drivers
- 12.2 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Market Restraints
- 12.3 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN)
- 13.3 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Typical Distributors
- 14.3 BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) is a relatively new generation, bacteria lipopolysaccharide fraction extracted from BCG vaccine. It has a strong immunomodulatory effect with higher efficacy and fewer side effects. It is commonly used as immunomodulators in the treatment of dermatitis and allergic diseases.
This report is a detailed and comprehensive analysis for global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhejiang Wansheng Pharmaceutical, Shaanxi Medicine Holding Group Biological Products, Jilin Yatai Biological Pharmaceutical, Chengdu Institute of Biological Products, Hunan Jiuzhitang Siqi Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nucleic Acid 40μg
Nucleic Acid 30μg
Market segment by Application
Hospital
Clinic
Major players covered
Zhejiang Wansheng Pharmaceutical
Shaanxi Medicine Holding Group Biological Products
Jilin Yatai Biological Pharmaceutical
Chengdu Institute of Biological Products
Hunan Jiuzhitang Siqi Biological
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN), with price, sales quantity, revenue, and global market share of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) from 2021 to 2026.
Chapter 3, the BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN).
Chapter 14 and 15, to describe BCG Polysaccharide and Nucleic Acid Injection (BCG-PSN) sales channel, distributors, customers, research findings and conclusion.